176 related articles for article (PubMed ID: 31842633)
1. Microsatellite instability and mismatch repair deficiency in the era of precision immuno-oncology.
Mann SA; Cheng L
Expert Rev Anticancer Ther; 2020 Jan; 20(1):1-4. PubMed ID: 31842633
[No Abstract] [Full Text] [Related]
2. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers.
González-Acosta M; Marín F; Puliafito B; Bonifaci N; Fernández A; Navarro M; Salvador H; Balaguer F; Iglesias S; Velasco A; Grau Garces E; Moreno V; Gonzalez-Granado LI; Guerra-García P; Ayala R; Florkin B; Kratz C; Ripperger T; Rosenbaum T; Januszkiewicz-Lewandowska D; Azizi AA; Ragab I; Nathrath M; Pander HJ; Lobitz S; Suerink M; Dahan K; Imschweiler T; Demirsoy U; Brunet J; Lázaro C; Rueda D; Wimmer K; Capellá G; Pineda M
J Med Genet; 2020 Apr; 57(4):269-273. PubMed ID: 31494577
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma.
Goeppert B; Roessler S; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Pfeiffenberger J; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2019 Jan; 120(1):109-114. PubMed ID: 30377340
[TBL] [Abstract][Full Text] [Related]
4. High homogeneity of mismatch repair deficiency in advanced prostate cancer.
Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S
Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of mismatch repair deficiency in gallbladder cancer.
Goeppert B; Roessler S; Renner M; Loeffler M; Singer S; Rausch M; Albrecht T; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M
Diagn Pathol; 2019 May; 14(1):36. PubMed ID: 31068195
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair deficiency: The what, how and why it is important.
Olave MC; Graham RP
Genes Chromosomes Cancer; 2022 Jun; 61(6):314-321. PubMed ID: 34837268
[TBL] [Abstract][Full Text] [Related]
7. Hypermutated Tumors and Immune Checkpoint Inhibition.
Ciombor KK; Goldberg RM
Drugs; 2018 Feb; 78(2):155-162. PubMed ID: 29350327
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair deficiency is implicated in carcinoma arising from ovarian teratoma.
Cheung AH; Chow C; Yu MY; Law WW; Law PP; Choi PC; Kang W; To KF
Pathology; 2019 Jan; 51(1):67-73. PubMed ID: 30502217
[TBL] [Abstract][Full Text] [Related]
9. Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies.
Ju JY; Dibbern ME; Mahadevan MS; Fan J; Kunk PR; Stelow EB
Am J Clin Pathol; 2020 Apr; 153(5):598-604. PubMed ID: 31844887
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy and patients treated for cancer with microsatellite instability.
Colle R; Cohen R; Cochereau D; Duval A; Lascols O; Lopez-Trabada D; Afchain P; Trouilloud I; Parc Y; Lefevre JH; Fléjou JF; Svrcek M; André T
Bull Cancer; 2017 Jan; 104(1):42-51. PubMed ID: 27979364
[TBL] [Abstract][Full Text] [Related]
11. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
12. [Microsatellite instability and cancer: from genomic instability to personalized medicine].
Collura A; Lefevre JH; Svrcek M; Tougeron D; Zaanan A; Duval A
Med Sci (Paris); 2019; 35(6-7):535-543. PubMed ID: 31274083
[TBL] [Abstract][Full Text] [Related]
13. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines.
Balmaña J; Balaguer F; Cervantes A; Arnold D;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi73-80. PubMed ID: 23813931
[No Abstract] [Full Text] [Related]
14. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine.
Gatalica Z; Vranic S; Xiu J; Swensen J; Reddy S
Fam Cancer; 2016 Jul; 15(3):405-12. PubMed ID: 26875156
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
17. DNA mismatch repair deficiency in lung and oral cavity carcinomas: the role of histogenetic origin.
Spetsotaki KN; Tsiambas E; Stamatelopoulos A; Fotiades PP; Kastanioudakis I; Tomos P; Ragos V
J BUON; 2017; 22(3):606-609. PubMed ID: 28730763
[TBL] [Abstract][Full Text] [Related]
18. A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes.
Gallon R; Mühlegger B; Wenzel SS; Sheth H; Hayes C; Aretz S; Dahan K; Foulkes W; Kratz CP; Ripperger T; Azizi AA; Baris Feldman H; Chong AL; Demirsoy U; Florkin B; Imschweiler T; Januszkiewicz-Lewandowska D; Lobitz S; Nathrath M; Pander HJ; Perez-Alonso V; Perne C; Ragab I; Rosenbaum T; Rueda D; Seidel MG; Suerink M; Taeubner J; Zimmermann SY; Zschocke J; Borthwick GM; Burn J; Jackson MS; Santibanez-Koref M; Wimmer K
Hum Mutat; 2019 May; 40(5):649-655. PubMed ID: 30740824
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
Xiao X; Dong D; He W; Song L; Wang Q; Yue J; Xie L
Gynecol Oncol; 2018 Apr; 149(1):146-154. PubMed ID: 29496294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
